Related Experiment Video
Updated: Aug 29, 2026

Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy
Published on: May 24, 2016
Dystrophinopathy caused by mid-intronic substitutions activating cryptic exons in the DMD gene
Christophe Béroud1, Alain Carrié, Chérif Beldjord
1Institut Cochin and Laboratory of Molecular Genetics, Cochin Hospital, Paris, France.
Abstract:
In the course of a mutation search performed by muscle dystrophin transcript analysis in 72 Duchenne and Becker Muscular Dystrophies (DMD/BMD) patients without gross gene defect, we encountered four unrelated cases with additional out-of-frame sequences precisely intercalated between two intact exons of the mature muscle dystrophin mRNA. An in silico search of the whole dystrophin genomic sequence revealed that these inserts correspond to cryptic exons flanked by one strong and one weak consensus splice site and located in the mid-part of large introns (introns 60, 9, 1M, and 62, respectively). In each case we identified an intronic point mutation activating the cryptic donor or acceptor splice site. The patients exhibited a BMD/intermediate phenotype consistent with the presence of reduced amounts of normally spliced transcript and normal dystrophin. The frequency of this new type of mutation is not negligible (6% of our series of 65 patients with 'small' mutations). It would be missed if the exploration of the DMD gene is exclusively performed on exons and flanking sequences of genomic DNA.
Insights
New mutations in the dystrophin gene involve cryptic exons, leading to Duchenne or Becker Muscular Dystrophy. These intronic mutations are often missed by standard genetic testing methods.
Area of Science:
- Genetics
- Molecular Biology
- Neuromuscular Disorders
Background:
- Duchenne and Becker Muscular Dystrophies (DMD/BMD) are genetic disorders caused by mutations in the dystrophin gene.
- Standard mutation detection often focuses on exons and flanking regions, potentially missing intronic mutations.
Observation:
- Four unrelated DMD/BMD patients without gross gene defects exhibited unexpected out-of-frame sequences in muscle dystrophin mRNA.
- These sequences originated from cryptic exons within large introns, activated by intronic point mutations.
Findings:
- In silico analysis identified cryptic exons with specific splice site characteristics in introns 60, 9, 1M, and 62.
- Intronic point mutations were found to activate these cryptic donor or acceptor splice sites, leading to altered mRNA splicing.
- Patients presented with a Becker Muscular Dystrophy/intermediate phenotype, with reduced normally spliced transcripts but normal dystrophin levels.
Implications:
- This study reveals a novel class of intronic mutations in the dystrophin gene, accounting for 6% of small mutations in the series.
- Current diagnostic approaches focusing solely on exons may overlook these cryptic exon-mediated mutations.
- Comprehensive genetic analysis including intronic regions is crucial for accurate DMD/BMD diagnosis.
Related Concept Videos
Satellite Stem Cells and Muscular Dystrophy
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon has three reading...
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Huntington Disease l: Introduction
Sex-linked Disorders

